novo nordisk glp 1 drugs Ozempic is first GLP-1 drug FDA-approved for kidney disease Novo Nordisk Abruptly Ends Partnership
Description
Many people tolerate tirzepatide just fine with manageable side effects
10.1002/ejhf.240 77 SaponaroF.SonaglioniA.RossiA.MontefuscoL.LombardoM.AddaG.et al (2016)
Lancet 376 , 393394 (2010)
It normally takes around 7 days to receive the medication
Vomiting Less common than nausea, affects about 15-20% of patients
L., Raghuram, V
